252 related articles for article (PubMed ID: 27207652)
21. DNA methylation in breast cancer.
Yang X; Yan L; Davidson NE
Endocr Relat Cancer; 2001 Jun; 8(2):115-27. PubMed ID: 11446343
[TBL] [Abstract][Full Text] [Related]
22. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
23. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
25. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
27. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract][Full Text] [Related]
28. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression.
Wang YA; Kamarova Y; Shen KC; Jiang Z; Hahn MJ; Wang Y; Brooks SC
Cancer Biol Ther; 2005 Oct; 4(10):1138-43. PubMed ID: 16131836
[TBL] [Abstract][Full Text] [Related]
29. ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation.
Thompson JJ; Kaur R; Sosa CP; Lee JH; Kashiwagi K; Zhou D; Robertson KD
Nucleic Acids Res; 2018 Nov; 46(19):10034-10051. PubMed ID: 30085123
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.
Kobayashi Y; Absher DM; Gulzar ZG; Young SR; McKenney JK; Peehl DM; Brooks JD; Myers RM; Sherlock G
Genome Res; 2011 Jul; 21(7):1017-27. PubMed ID: 21521786
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K
Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466
[TBL] [Abstract][Full Text] [Related]
34. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
35. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
[TBL] [Abstract][Full Text] [Related]
36. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes.
Schmitz KM; Mayer C; Postepska A; Grummt I
Genes Dev; 2010 Oct; 24(20):2264-9. PubMed ID: 20952535
[TBL] [Abstract][Full Text] [Related]
37. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
39. Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
Ghazi T; Nagiah S; Naidoo P; Chuturgoon AA
Epigenetics; 2019 Aug; 14(8):804-817. PubMed ID: 31060424
[TBL] [Abstract][Full Text] [Related]
40. Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
Raynal NJ; Lee JT; Wang Y; Beaudry A; Madireddi P; Garriga J; Malouf GG; Dumont S; Dettman EJ; Gharibyan V; Ahmed S; Chung W; Childers WE; Abou-Gharbia M; Henry RA; Andrews AJ; Jelinek J; Cui Y; Baylin SB; Gill DL; Issa JP
Cancer Res; 2016 Mar; 76(6):1494-505. PubMed ID: 26719529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
